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Abstract
Liver-specific ablation of cytochrome P450 reductase in mice (LCN) results in hepatic steatosis that can
progress to steatohepatitis characterized by inflammation and fibrosis. The specific cause of the fatty liver
phenotype is poorly understood but is hypothesized to result from elevated expression of genes encoding
fatty acid synthetic genes. Since expression of these genes is known to be suppressed by polyunsaturated
fatty acids, we performed physiological and genomics studies to evaluate the effects of dietary linoleic and
linolenic fatty acids (PUFA) or arachidonic and decosahexaenoic acids (HUFA) on the hepatic phenotypes
of control and LCN mice by comparison with a diet enriched in saturated fatty acids. The dietary
interventions with HUFA reduced the fatty liver phenotype in livers of LCN mice and altered the gene
expression patterns in these livers to more closely resemble those of control mice. Importantly, the
expression of genes encoding lipid pathway enzymes were not different between controls and LCN livers,
indicating a strong influence of diet over POR genotype. These analyses highlighted the impact of POR
ablation on expression of genes encoding P450 enzymes and proteins involved in stress and inflammation.
We also found that livers from animals of both genotypes fed diets enriched in PUFA had gene expression
patterns more closely resembling those fed diets enriched in saturated fatty acids. These results strongly
suggest only HUFA supplied from an exogenous source can suppress hepatic lipogenesis.
Keywords: cytochrome P450 reductase, functional genomics, gene set analysis
ඉඋൾඌൾඇඍ ඎ.ඌ. ඌඈർංൾඍඒ benefits, and suffers, from the great technological advances made that have increased
our ability to produce an abundance of food while decreasing the amount of time and physical energy spent
obtaining food. At the same time, we have stressed our environment and introduced into it chemicals that
can alter physiological parameters and influence gene expression. Many nutrients and environmental toxins
are metabolized by the cytochrome P450 system. In the liver, the P450 system plays a critical role in bile
acid synthesis on the one hand and detoxification of environmental chemicals, drugs, and xenobiotics on
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Animal husbandry and dietary protocols.
the other, functions that are much appreciated and the subject of intense investigations. However, the role
of P450 enzymes in metabolism of nutrients and natural metabolites remains poorly understood. Among
these are P450 enzymes that catalyze the conversion of long chain highly unsaturated fatty acids to
bioactive compounds.
The liver-specific cytochrome P450 reductase (NADPH-hemoprotein reductase, EC 1.6.2.4, CPR, or POR)
knockout (LCN) mouse, a model in which the gene for POR, the master enzymatic regulator of microsomal
P450 metabolism, has been selectively deleted from the liver, was observed to display a fatty liver
phenotype with characteristics in common with nonalcoholic fatty liver disease (NAFLD) (13, 16). These
characteristics include steatosis involving accumulation of triglycerides and cholesterol esters, eventual
development of fibrosis, and evidence of inflammation. Previously we had provided evidence that the fatty
liver phenotype was coincident with an accumulation of the C18 polyunsaturated fatty acids C18:2ω6 and
C18:3ω3 [linoleic (LA) and linolenic (LN) acid, respectively; collectively called PUFA] when mice were
fed a standard chow diet (45). This PUFA accumulation occurs at the expense of the synthesis of the very
long chain highly unsaturated fatty acids C20:4ω6, C20:5ω3, and C22:6ω3 (AA, EPA, and DHA,
respectively; collectively called HUFA) and levels of these fatty acids are decreased in livers from LCN
mice compared with livers from control animals. Transcription profiling demonstrated that this probably
occurred due to downregulation of specific elongase and desaturase enzymes required for HUFA synthesis.
These results were unanticipated because previously there was no known connection between the P450
system and fatty acid elongation and desaturation. The reductase activity associated with the fatty acid
desaturase enzymes (Fads1 and Fads2) is not POR. However, it is known that members of several
cytochrome P450 enzyme (CYP) families including CYP1, CYP2, CYP3, CYP4, and CYP5 function in the
metabolism of C20:4ω6 (arachidonic acid) to form bioactive regulatory eicosanoids (reviewed in Ref. 30).
The role of these enzymes in the metabolism of C20:5ω3 and C22:6ω3 fatty acids is less well studied.
Therefore, the importance of the LCN model lies in the opportunity to uncover important integrative
relationships between lipid homeostasis and other metabolic pathways including the detoxification of drugs
and elimination of toxic environmental factors.
In the present study, we explored the hypothesis that the fatty liver phenotype and associated gene
expression changes that occur with the specific deletion of the Por gene in adult mouse liver could be
abrogated by supplementation of the mouse diet with the HUFA, arachidonic acid (AA, C20:4ω6),
eicosapentaenoic acid (EPA, C20:5ω3) and docosahexaenoic acid (DHA, C22:6ω3). As we expected the
fatty liver phenotype was not reduced by the PUFA linoleic (LA, C18:2ω6) and linolenic (LN, C18:3ω3),
since these accumulated in the fatty livers of LCN animals. However, we also made two surprising
observations. First, control animals fed a diet enriched in PUFA had fatty livers and gene expression
profiles similar to animals fed a lard diet, which was deficient in both PUFA and HUFA. Second, while a
diet enriched in HUFA did result in reduced steatosis in livers of the LCN animals, fat accumulation was
still elevated relative to controls. Array analyses indicated that most differences in gene expression that
were related to fatty acid metabolism in the LCN livers could be attenuated by modification of the fat
composition of the diet.
MATERIALS AND METHODS
Generation of the founder line with hepatic ablation of Por is
described in Wu et al. (48). Male test animals used in this study had the genotype Alb-Cre /Por  and
were designated LCN. The control animals were co-isogenic male mice with the genotype Alb-Cre
/Por . The test and control animals were derived from intercrosses between Alb-Cre /Por  and
Alb-Cre /Por  mice; the breeders had been backcrossed for at least 10 generations onto the C57BL/6
background. All animal procedures were approved by the Wadsworth Center Institutional Animal Care and
Use Committee of the New York State Department of Health.
+/− lox/lox
−/−
lox/lox +/− lox/lox
−/− lox/lox
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Sample collection.
Blood chemistry.
Lipid analyses.
RNA isolation and quantitative RT-PCR.
Upon weaning (4 wk after birth) 6–12 male mice of each genotype were placed on one of the test diets for
8 wk. Siblings of the same genotype were randomized between dietary groups. Synthetic diets used base
diet AIN-93G and contained 18.7% protein, 64.7% carbohydrate, 5% fiber, 6% fat, 0.025% cholesterol,
0.008% sodium cholate, and 3.97 kcal per gram. The added fats were as follows: 6% lard (lard diet), 6%
canola oil (canola diet), or 2.73% menhaden oil (fish/fungal diet) and 3.27% ARASCO oil (Martek
Biosciences). The synthetic chows were stored in evacuated and sealed plastic bags at −80°C until use. The
complete fatty acid composition of the diets is given in Sealls et al. (36). Weight gain and body length
(from the nose to anus) were monitored once a week, and no differences were detected between genotypes
or diets. Food was changed frequently and fatty acid analysis by gas chromatography/mass spectrometry
(GC-MS) was repeated periodically to assure the unsaturated fats were not oxidized and or otherwise
modified.
After 8 wk on the test diets (12 wk of age) the animals were fasted for 4 h prior to
death. Venous blood was drawn from the heart and collected in lithium heparin-coated tubes; 50 μl of
whole blood was saved for analysis and plasma was obtained by centrifugation of the remaining blood.
Both whole blood and plasma were immediately stored at −20°C for further analysis. Liver samples were
placed in RNAlater for mRNA analysis, in OCT tissue-Tex for histology, or were immediately frozen and
stored at −80°C.
One week before the mice were killed they were fasted for 12 h and blood was obtained
by tail clipping. Glucose was measured using a glucometer and test strips (ACCU-CHECK Active, Roche).
Plasma cholesterol and triglyceride (Tg) levels were determined after terminal bleed with commercially
available kits (Wako Diagnostics) following the manufacturer's instructions. Liver function was measured
by analysis of 4 h fasted whole blood using a mammalian liver profile rotor in a VetScan classic
hematological analyzer (Abaxis).
Total lipid extraction from liver samples was performed according to Folch's method (11).
All the lipid extractions were carried out in the presence of the antioxidant β-hydroxy-toluene (0.05%,
wt/vol). Heptadecanoic and nonadecanoic acid (100 μg each) were added to all samples to estimate the
recovery of fatty acids. For fatty acid analysis, complex lipids were hydrolyzed by adding 0.5 ml of
methanol containing 1% (wt/vol) sulfuric acid and 0.25 ml of toluene to each sample. The samples were
incubated at 60°C overnight. After this period 1.25 ml of water containing sodium chloride (5%, wt/vol)
was added and the required esters were extracted with hexane (2 × 1.25 ml). The hexane layer was washed
with water (1 ml) containing potassium bicarbonate (2%, wt/vol) and dried over anhydrous sodium sulfate.
The solvent was removed under a stream of nitrogen and the fatty acid methyl esters were analyzed by
GC/MS using an Agilent 6890 series gas chromatograph equipped with a 5873 mass-selective detector. For
assessment of sterols, 100 μg 5α-cholestane was added to samples as an internal standard. Sterols were also
separated and detected by GC/MS using a DB-17ms column (Agilent).
RNA was extracted using a Qiagen RNeasy mini kit and reverse
transcribed to cDNA using Bio-Rad iScript cDNA synthesis kit for production of a template for
quantitative (Q)-PCR. Reactions were performed in a 96-well plate format using a Bio-Rad iCycler. Each
Q-PCR reaction contained the following: 12.5 μl of Bio-Rad iQ SYBR Green Supermix, 500 nM of each
primer (Supplemental Table S1) , 1–6 μl of cDNA, and milliQ H O up to a total volume of 25 μl. For all
genes studied, standard curves were generated using serial dilutions of the corresponding PCR product
using the primers specified. The PCR products had been previously purified using a Qiagen PCR
purification kit and the concentration measured using a NanoDrop. Total copy number/μl was calculated
with the following equation: {[(DNA)/molecular weight of fragment] × 6.023 × 10 }. Q-PCR
amplification was set using the following parameters: a denaturing cycle of 3 min at 95°C; 30 cycles of
PCR 95°C for 30 s, annealing temperature specific to each primer set for 30 s, and 72°C for 30 s; a melt
1 2
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Microarray analysis.
Pathway and gene ontology studies by gene set enrichment analysis.
cycle consisting of 95°C for 1 min, 55°C for 1 min, and a step cycle starting at 55°C and ending at 95°C
increasing by 5°C increments for 10 s each. Standard curve generation, quantification of cDNA, and melt
curve generation were performed with the Bio-Rad iQ-PCR cycler. Each hepatic gene quantified for the
lard, canola, and fish/fungal diets was then corrected for varying cDNA microgram inputs (each was set
equivalent to 100 ng of input RNA). Results for each gene is presented relative to the values obtained for
livers from control mice fed the lard diet.
Total RNA was isolated from the livers of mice as described above for Q-PCR. To
reduce variability between arrays, three RNA samples from individual mice of the same genotype/diet
group were pooled using equivalent RNA amounts for each animal (3 biological replicates for each
diet/genotype combination). The quality of RNA was analyzed using an Agilent 2100 Bioanalyzer. Three
micrograms of RNA was reverse transcribed to make cDNA. Hybridization of cDNA, washing, and
scanning of the Affymetrix GeneChip Mouse Genome 430 2.0 (containing 45,101 probe sets representing
over 34,000 mouse genes) was performed according to the standard Affymetrix protocol (performed by The
Applied Genomics Technologist Core at the New York State Department of Health, Wadsworth Center).
Data analysis was performed, in part, using GeneSpring GX 9.0 software. Probe data from the gene chips
were corrected for background, normalized, and summarized using the robust multiarray analysis (RMA)
method (18). This was followed by linear models of gene expression corrected with empirical Bayes
models as implemented in the new limma package extended from reference (37). Both RMA and limma are
packages of the Bioconductor Suite (12). Raw data were transformed to base-2 logarithms for better
visualization and to give equal emphasis on both up- and downregulated genes. The array data have been
deposited in the National Center for Biotechnology Information Gene Expression Omnibus database with
accession number GSE20944. For the main effect of genotype and diet, log  fold change was calculated
relative to the genotype or diet indicated. Genes whose expression changed relative to both diet and
genotype interactions were expressed as the raw log  transformed data. In other calculations, the main
effect of genotype was calculated using a t-test (using an asymptotic P value computation) with a P value
cutoff of P < 0.05. Main effect of diet was calculated first by ANOVA followed by Tukey's honestly
significant difference (HSD) (using an asymptotic P value computation) with a P value cutoff of P < 0.05.
Interaction between genotype and diet was calculated using a two-way ANOVA with a P value cutoff of P
< 0.05. False discovery rate (FDR) was calculated according to Benjamini and Hochberg and applied to the
independent main effects (genotype or diet) but not the interaction effect (3, 34).
To identify
biochemical/signaling pathways or Gene Ontology (1) categories that were significantly differentially
regulated, we used rigorous Gene Set Enrichment Analysis (GSEA) (40). GSEA calculates enrichment on
the basis of all genes on the chip as opposed to ad hoc methods based on the biased samples of up- or
downregulated genes. GSEA estimates the statistical significance of enrichment in the upregulated and
downregulated categories. For example, gene sets as a whole may be significantly upregulated even when
the upregulation of most individual genes is not significant. We performed 10,000 random permutations of
all genes for the permutation tests. Multiple test correction was performed by FDR using a threshold of
FDR ≤ 0.05 (3, 34).
Most biochemical and signaling pathways were obtained from the Curated Dataset (C2) of the Molecular
Signature Database created by the GSEA Team that we mapped from human genes to their mouse
orthologs (40). We also used the Kyoto Encyclopedia of Genes and Genomes Pathways Database (KEGG,
31). Gene Ontology sets for biological processes, molecular functions, and cellular localizations (1) were
downloaded from the Gene Ontology Consortium (http://www.geneontology.org/GO.downloads.shtml).
Gene set databases were adapted for GSEA using our PERL libraries (University of Nebraska - Lincoln,
Department of Statistics). GSEA was performed on a command-line interface at a 16 gb RAM LINUX
server.
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Western blot analysis.
Statistical analysis.
Physiological and histological examination of control and LCN mice fed diets varying in lipid
composition.
Livers were mechanically disrupted by homogenization on ice in 20 mM Tris·HCl
pH 7.5, 150 mM NaCl, 1 mM Na EDTA pH 7.4, 1 mM EGTA pH 7.5, 0.1% Triton, 2.5 mM Na
pyrophosphate, 1 mM Na VO  1 μg/ml leupeptin, and one protease inhibitor cocktail tablet (Roche) per 50
ml. For fatty acid synthase (FASN) 20 μg of total protein was separated on an 8% SDS-PAGE gel and
transferred to a nitrocellulose membrane. The membrane was blotted using anti-FASN at 0.5 μg/μl.
Secondary anti-rabbit horseradish peroxidase (HRP) was used at a 1:5,000 dilution. β-Actin (antibody
dilution of 1:10,000) was used as a loading control. For Scd1, microsomes were prepared according to
Coon et al. (7). In brief, liver homogenates (above) were centrifuged at 10,000 g for 20 min at 4°C.
Supernatants were recovered and centrifuged at 110,000 g for 1 h, at 4°C. Pellets containing the
microsomes were washed twice with cold pyrophosphate buffer (100 mM sodium pyrophosphate pH 7.4, 1
mM EDTA) and then resuspended and sonicated in cold storage buffer (50 mM Tris-acetate pH 7.4, 20%
glycerol, 0.1 mM EDTA). To detect Scd1 30 μg of microsomal protein was separated on a 12% SDS-PAGE
gel and transferred to a nitrocellulose membrane. The membrane was blotted using anti-Scd1 antibody
from Santa Cruz Biotechnology (sc-14719) at a 1:200 dilution. Secondary anti-goat HRP antibody from
Santa Cruz Biotechnology was used at a 1:5,000 dilution. Proteins were visualized using an ECL kit
(Pierce) according to the manufacturer's instructions. Protein concentrations were determined using the
Bio-Rad protein assay kit according to manufacturer's instructions. BSA was used as a standard.
Unless otherwise indicated lipid, plasma chemistry and Q-PCR data were analyzed by
two-way ANOVA followed by Tukey's HSD or t-test (JMP statistical analysis software). Gene expression
array data was analyzed as described above.
RESULTS
Livers of LCN mice are steatotic when mice are reared on standard rodent chow (13, 16). To determine if
steatosis could be reduced and differences in gene expression for lipid metabolic enzyme normalized
despite POR deficiency, we performed a dietary study in which the mice were reared from weaning until 12
wk of age on three defined diets differing only in fat composition, which included lard (limited in PUFA
and HUFA), canola oil (enriched in PUFA), or a mixture of Menhaden and ARASCO oils (fish/fungal,
enriched in HUFA) (36). The diets were not high in calories, fat, or carbohydrate. We expected the high
percentage of HUFA in the fish/fungal diet would dampen fatty acid and triglyceride synthesis to limit
steatosis in the LCN animals (4, 23). Both LCN and control mice grew well on each diet, and there were no
significant differences in growth between genotypes or diets (Table 1). Liver size was not affected by
dietary treatment, but livers of LCN mice were significantly larger than their control counterparts, and this
was reflected in a slightly higher liver to body weight ratio.
Plasma chemistry parameters, glucose, and lipid levels were assessed to evaluate the effect of different
dietary fat compositions on animals of each genotype (Table 1). Blood ALP and ALT varied significantly
with genotype whereby the LCN animals had higher levels than controls possibly indicative of hepatic
stress. Fasting blood glucose levels measured after a 12 h fast were not different between LCN and control
animals but were significantly lower when animals were fed the fish/fungal diet (36). Plasma cholesterol
levels were low in LCN animals compared with controls as previously reported (16), and this was only
partially alleviated by dietary fat treatment. Animals on the lard based diet had the highest plasma
cholesterol levels followed by canola and fish/fungal fed animals. The levels for the LCN mice were more
similar to the controls maintained on the fish/fungal diet. The plasma triglyceride (Tg) levels were low in
the LCN animals compared with controls and partially affected by diet. In each case animals fed the
fish/fungal diet had lower levels of plasma Tg than animals on lard or canola based chows.
2
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Liver fatty acid profiles are modified by genotype and diet.
A notable phenotype of the LCN model is hepatic steatosis. One of the goals of the present study was to
alter fat accumulation by treatment with different dietary fats. Since we had previously noted livers of these
mice were relatively enriched in the PUFAs over HUFAs, we hypothesized feeding a HUFA-enriched diet
would suppress fatty acid synthesis and excessive accumulation of Tg. Histological examination revealed
extensive lipid droplet accumulation in livers of control animals fed lard and canola, which was even more
exaggerated in livers from the LCN mice (Fig. 1). We found hepatic lipid accumulation was favored and
was similar when mice were fed either the lard or canola diets regardless of genotype (Fig. 2A). The
amount of Tg that accumulated in LCN livers from animals fed the fish/fungal diets was about half the
amount for livers of animals of the same genotype fed either the lard or canola diets. However, the amount
of Tg that accumulated in livers of the LCN mice on any diet was still higher than that of control livers.
This was surprising since, as reported below, expression of most fatty acid synthetic genes were suppressed
by fish/fungal feeding regardless of genotype.
Hepatic cholesterol synthesis is largely dependent upon POR function since pathway enzymes leading from
lanosterol to cholesterol and bile acids are dependent upon P450 enzymes. Therefore both synthesis and
clearance of cholesterol from liver is compromised in the LCN animals. The levels of cholesterol were
measured using a standard kit (Fig. 2B) and by GC/MS analysis to identify cholesterol and other sterol
precursors and metabolites. LCN livers had higher levels of hepatic cholesterol than control animals. The
greater sequestration of cholesterol in the LCN livers than in the control livers was probably because
cholesterol was not eliminated as bile.
Due to the defect in P450 reductase, it was expected that the de novo synthesis of cholesterol would be
halted or compromised at steps beyond squalene due to insufficient squalene epoxidase (CYP51) activity.
As predicted we found squalene to accumulate to high levels in the LCN livers (0.34 ± 0.07 mg/g liver)
compared with controls (0.05 ± 0.01 mg/g liver) (P = 0.002). In contrast, there was no significant
difference specifically due to diets (data not shown).
Liver synthesizes saturated and
monounsaturated fatty acids de novo from acetyl-CoA usually derived from dietary carbohydrate.
Preformed fatty acids may also be acquired from the blood stream, and these are generally thought to be
derived from lipoproteins during the fed state and from free fatty acids originating from adipose tissue
lipolysis during fasting. Hepatocytes elongate and desaturate the essential PUFA, C18:2ω6 (LA) and
C18:3ω3 (LN), to form the HUFA, C20:4ω6 (AA), C20:5ω3 (EPA), and C22:6ω3 (DHA). One of the
questions arising from the present study was: what is the interrelationship between dietary fatty acids and
hepatic gene expression, particularly with regard to lipid synthesis? Our previous analyses, comparing fatty
acid profiles of animals of each genotype fed a standard lab chow, suggests that liver specific deletion of
Por resulted in suppression of elongation and desaturation of PUFA, resulting in low levels of HUFA in
these animals compared with controls (45). We therefore analyzed hepatic fatty acids from livers of animals
of both genotypes on each of the synthetic test diets. The present data were analyzed in two ways. First the
total amount of fatty acid was measured and expressed in μmol/g wet weight of tissue (Supplemental Table
S2). This verified total lipid accumulated in the LCN livers was higher than in control livers. Second, these
data were analyzed as mol% of each class of fatty acid relative to the total fatty acid in the sample to
facilitate assessment of the relative amount of any fatty acid acquired from the diet or synthesized de novo (
Table 2). Monounsaturated fatty acids made up 50–60 mol% of all fatty acids when mice of either genotype
were fed the lard- or canola-based diets. Since this is higher than the amount provided in the diets, it
suggests efficient conversion of the saturated fatty acids to the monounsaturated and/or net synthesis. The
relative abundance of monounsaturated fatty acids was much lower in the fish/fungal diet groups, than in
the other two diet groups, for either genotype. Furthermore, the control animals maintained on the
fish/fungal diet had twofold higher levels of saturated fatty acids than monounsaturated fatty acids, while
the fish/fungal-fed LCN animals had essentially equivalent levels for the two groups of fatty acids. This
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Manipulation of dietary fat alters gene expression profiles irrespective of POR genotype.
indicates the fish/fungal diet suppresses the expression and/or activity of the Δ9-acyl-CoA desaturase
encoded within the Scd1 gene (see below).
The PUFA cannot be synthesized de novo in mammals and must be obtained in the diet. Therefore, tissue
PUFA content reflects accumulation and retention of these fatty acids from a dietary source. The canola oil
diet contained 37% PUFA at a ratio of 2:1, C18:2ω6 to C18:3ω3. However, the livers of control and LCN
mice fed the canola diet accumulated only 12–13% PUFA. Since there was very little HUFA (approx.
0.1%) provided in the canola diet, any amount accumulated in liver should be derived from anabolism of
dietary PUFA. While livers of animals of both genotypes fed the canola diet had measurable amounts of
HUFA, the LCN livers only accumulated half as much as the control livers, suggesting a reduction in
metabolic synthesis compared with controls. The fish/fungal diet contained about 37% HUFA at a ratio of
2:1 C20:4ω6 to C20:5ω3 and C22:6ω3. Fatty acid profiles in livers from animals of both genotypes fed
the fish/fungal diet each accumulated a high level of HUFA (35.4 vs. 31.1 mol%). Therefore, we had
achieved one goal in elevating liver HUFA levels in both the control and LCN livers. This was necessary to
assess impact on the liver transcriptome as detailed below.
Previous
expression analysis of livers from LCN and control mice fed standard rodent chow diets identified
numerous differences particularly with respect to genes encoding cytochrome P450 enzymes and genes
involved in fatty acid metabolism (29, 45). Since HUFA are known to suppress hepatic lipid synthesis, we
evaluated gene expression array results for livers from mice of each genotype on the three test diets. Data
were compared using two-way ANOVA to assess differences between diets and genotypes and interactions
between diets and genotype.
The largest number of gene expression differences, 80 in total, was detected by comparisons between diets,
regardless of genotype (Table 3). Surprisingly, expression of 57 of these was similar between lard and
canola by comparison with fish/fungal, while only seven were found to be in common between canola and
fish/fungal compared with lard. In all but eight cases the gene expression level was lower in livers of mice
fed the fish/fungal diets. Notable among these eight was Acsm2, encoding a medium chain acyl-CoA
synthetase found in the mitochondria (5), and Gpcpd1, a putative glycerophosphocholine
phosphodiesterase (32). These enzymes may be involved in maintaining fatty acid and glycerolipid
homeostasis when animals are fed diets enriched in HUFA.
Many of the genes whose expression was found to be similarly high between livers of mice fed the lard and
canola diets were fatty acid and sterol synthetic genes (Table 3). Among these were Acly, encoding the
ATP-citrate lyase, which provides cytosolic acetyl-CoA for both fatty acid and cholesterol synthesis;
acetyl-CoA carboxylase subunit gene (Acacb); Fasn; the fatty acid elongase genes fatty acid elongase
(Elovl) 2 and Elovl 5; and the fatty acid desaturase genes Fads1 and Fads2. Two fatty acid binding protein
genes, Fabp2 and Fabp5, required for intracellular fatty acid transport and trafficking, were highly
expressed in lard and canola versus fish/fungal fed livers. However, Fabp5 expression was unique in that
expression in livers of canola fed mice was only 40% of that in lard-fed mice, indicating PUFA as well as
HUFA may suppress this gene's expression in liver. Fifteen genes involved in sterol metabolism were
identified as significantly different. Again, most were expressed in a similar manner when comparing livers
from animals fed the lard or canola diets, and most were low when animals were fed the fish/fungal diets.
Among these was Insig1, which regulates the processing of both SREBP1 and SREBP2 to the mature
active form of these transcription factors. Overall, this pattern of fatty acid and sterol gene expression
indicates both SREBP1 and SREBP2 are highly active in livers of animals fed either the lard or canola
diets. These findings emphasize the impact of dietary HUFA over dietary PUFA in regulating gene
expression through SREBP1 in particular.
Expression of three apolipoprotein genes was high in livers from lard and canola fed mice compared with
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fish/fungal. The ApoA4 gene was remarkable in that it was very strongly expressed (8- to 8.5-fold) in livers
of lard- and canola-fed mice compared with the fish/fungal diet. This gene is found in a cluster with ApoC3
and ApoA5 (8). ApoA4 is a dynamic protein that has been found to be associated with both chylomicrons
and high-density lipoproteins and is implicated in diseases associated with elevated lipid levels (33, 46). It
is an activator of lecithin-cholesterol acyltransferase (LCAT) and has also been implicated as a satiety
signal (39). ApoA5 was more highly expressed in liver of mice fed lard or canola diets compared with
fish/fungal. Allelic variants of this protein have been associated with hypertriglyceridemia (9, 15).
Elevation of genes encoding these lipoproteins by the lard and canola diets is consistent with high levels of
lipid synthesis and trafficking that would result in elevated plasma lipids.
The primary source of calories in the base diet was from carbohydrate (66.5% kcal/g) and did not differ
between the three test diets. Few genes were identified as significantly different that were involved in
carbohydrate metabolism, and those identified were not necessarily indicative of control by ChREBP, the
major carbohydrate-responsive transcription factor. Neither were the identified genes suggestive of
coordinate control between SREBP1 and ChREBP. These observations suggest the differences in the type
of fatty acid supplied in our test diets did not have a significant impact on carbohydrate responsive gene
expression.
Among the genes involved in regulation that were identified as significantly different due to diet, were
several that have been implicated in Type 2 diabetes and cardiovascular disease, including Vegf-B and
calmodulin-dependent kinase 1d (Cdc123/Camk1d). Vegf-B has been implicated in the regulation of genes
involved in fatty acid uptake and mitochondrial metabolism (14). Camk1d was indentified in genome-wide
association studies for Type 2 diabetes susceptibility loci (50).
For the biostatistical analyses at the level of metabolic and regulatory pathways we used GSEA, which
evaluates microarray expression datasets not at the level of individual genes but at the level of gene sets
based on published information of biochemical function and coexpression patterns (40). GSEA is a
statistically robust method because a normalized enrichment score is computed based on all members of a
gene set compared with all nonmembers measured. Supplemental Table S3 lists the gene sets that were
significantly different using a 5% FDR threshold for at least one comparison between diets. As expected,
among the six top pathways identified were five sets related to lipid synthesis. Interestingly, oxidative
phosphorylation was identified as significantly different only for the canola versus lard comparison.
GSEA identified two peroxisome proliferator-activated receptor (PPAR)α pathways as strongly influenced
by dietary fatty acid. This is plausible since both PPARα and sterol regulatory element binding protein
(SREBP) 1 activities are regulated by DHA (reviewed in Ref. 19). SREBP1 and PPARα co-regulate, among
others, genes encoding elongases and desaturases required to synthesize HUFA from PUFA. For most other
regulatory pathways identified, there was a general pattern of downregulation by the fish/fungal diet.
Notable exceptions included prostaglandin synthesis regulation and G protein signaling, which were only
significantly different for the canola versus lard comparison. In the nuclear receptor category, only the
fish/fungal versus canola comparison was identified.
Many inflammation- and infection-related pathways emerged by GSEA. At least 12 of the identified
pathways were significantly different for both fish/fungal versus lard and canola versus lard. Interesting
exceptions included the complement and coagulation cascades and the related blood clotting cascade gene
sets, each of which was significantly different only for the canola versus lard comparison. These
distinctions are likely to indicate unique regulatory cascades are responsible for the observed regulatory
patterns due to dietary PUFA versus HUFA.
Other GSEA pathways identified could be generally grouped into those involved in cell cycle and division
or cell structure and adhesion. There is evidence in the literature for control of each process by dietary fatty
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Differences in gene expression between LCN and control livers irrespective of diet.
Diet-gene interactions affect liver transcriptome.
acids and/or fatty acid regulated transcription factors such as PPARα and SREBP1 (e.g., see Ref. 22).
Taken together, these data indicate the HUFA in the fish/fungal diets, particularly DHA have a dominant
effect on gene expression compared with the lard and canola diets, which have low levels of HUFA and
differ between each other in the relative amount of PUFA. However, as noted, some regulatory patterns
could not be explained by HUFA effects alone and were observed to either be influenced by the PUFA
alone or by both PUFA and HUFA.
We estimated that
71 genes were differentially expressed specifically due to genotype at P ≤ 0.05 (Table 4). Of these 63 were
higher in LCN livers compared with controls and eight were lower. It is important to note that feeding the
synthetic diets differing only in fat composition eliminated many of the apparent differences in expression
of genes involved in fatty acid and sterol metabolism that we previously reported for control and LCN mice
fed a standard chow diet (compare data in Ref. 45 with Table 4). In fact, the only gene related to fatty acid
metabolism identified as significantly different due to genotype was Lpl encoding lipoprotein lipase
(2.5-fold higher for LCN livers than control livers). This protein is required for hydrolysis of Tg from
lipoproteins in the bloodstream and its activity is a prerequisite for subsequent fatty acid uptake into cells.
At least 17 identified genes were associated with oxidative stress and inflammation probably reflecting the
compensation for hepatic dysfunction associated with POR ablation. Six genes encoding cytochrome P450
enzymes were also upregulated, while expression of one, Cyp2u1, was low in the LCN livers. A number of
phase II drug-metabolizing enzymes were also identified including Gstm3, which has been identified as a
cancer susceptibility gene (24, 49). Many of these gene changes correlate with those previously observed
for the POR knockout animals and were not unexpected (43, 45). Our unique finding, as noted above, was
the elimination of the lipid metabolic pathway genes as significantly different between genotypes.
We also performed GSEA pathway analysis by including all array datasets without consideration of diet (9
each for control and LCN) using an FDR q-value of ≤ 0.25. Although relatively high, this threshold is
considered useful to provide biological insights (40). Employing these criteria, 53 pathway gene sets were
identified (Supplemental Table S4). Only four of the identified pathways were coincident with those
identified as different due to diet: prostaglandin synthesis regulation, HSA05220 chronic myeloid
leukemia, HSA04110 cell cycle, and cell cycle Kegg. Interestingly, in the Molecular Signature Databases
(Broad Inst.) used, four pathway sets are included from our previous report on the LCN gene expression
array data (45). However, none of these were identified in our GSEA as significantly enriched even at an
FDR q-value of ≤ 0.25. These results point to the dominant effect of diet over genotype uncovered in the
present studies.
Array data for livers from animals of each genotype
fed each of the three diets was analyzed using two-way ANOVA to examine interactive effects between
genotype and diet (GeneSpring software). However, we found that if FDR was applied for multiple test
correction, no genes were identified as significantly different suggesting the interactive effects between
genotype and diet were subtle. Without applying a correction but using a P value of < 0.01, 22 genes were
identified whose expression was influenced by both diet and genotype (Table 5). Among these, one gene
was identified that is required for fatty acid elongation, Elovl 1. Also identified were the genes encoding
lipoprotein lipase (Lpl) and lipocalin 13 (Lcn13), two proteins implicated in fatty acid transport. Lcn13
expression was highest in the control livers from mice fed the fish/fungal diet, while Lpl expression was
highest in the LCN livers on the fish/fungal diet. Both genes had low expression in livers when the animals
had been fed the lard or canola diets. While the function of Lpl is very well defined, that of Lcn 13 is not.
Lipocalins are members of a family of secreted proteins that bind and transport small hydrophobic
molecules. One family member Lcn2/NGAL has been implicated in inflammatory response (41, 42, 44)
and is suggested as a biomarker of kidney disease (26, 38). Identification of Lcn13 as a factor affected by
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Examination of gene expression patterns for selected genes by Q-PCR and Western analysis.
both dietary fat and hepatic POR indicates it should be explored as a sensitive biomarker of liver function.
Fewer genes associated with inflammation and P450 function were identified as being affected by both
genotype and diet as were identified by comparisons of genotype effects alone.
It should be pointed out that many of the genes identified as differentially expressed due to interaction
between genotype and diet did not cluster into easily identifiable categories. Among these were several
regulatory proteins including Vegf-B, Creb family member Creb3l2, and G protein-coupled receptor 137b.
Previous studies showed that Vegf-B overexpression in cardiomyocytes results in accumulation of
ceramide, decreased triglyceride, increased mitochondrial lysis, and accumulation of intracellular lipid
membrane vacuoles (21). A recent paper demonstrated Vegf-B targets fatty acids to endothelial cells by
upregulating expression of fatty acid transport proteins (14). Creb3l2 has been implicated in regulating the
unfolded protein response (2, 25).
Q-PCR
of selected genes was performed using RNA from individual liver samples from six to eight separate mice
maintained on each diet to further evaluate apparent expression changes due to diet, genotype, and the
interaction between diet and genotype. Among the genes identified as most significantly sensitive to dietary
fatty acid by expression array analysis, we focused on those encoding Fasn, fatty acid elongase 2 (Elovl 2)
and ApoAIV (Fig. 3A). As expected each was significantly different for the diet comparison. ApoAIV was
also determined to be significant at the level of genotype but no interactions were detected. Expression of
the Δ9-stearyl CoA desaturase gene Scd1 is often reported to be sensitive to dietary fat. Because it was not
identified in our array analyses, we examined its expression by Q-PCR as well. We found there was
substantial between-animal variation in Scd1 expression that precluded establishment of statistically
significant differences. However, there was a strong trend for higher expression in livers of mice fed the
lard and canola diets compared with those of mice fed the fish/fungal diet. Protein levels of Fasn and Scd1
followed the same QPCR patterns (Fig. 4).
Two genes, Gstm3 and SerpinA1, that were found to be significantly different between genotypes by array
analysis, were also selected for Q-PCR (Fig. 3B). Expression of Gstm3 was significantly higher in the LCN
livers compared with controls. SerpinA1 was lower in the knockout livers but this difference was not
statistically significant (P = 0.078). Neither was significantly different when diets were compared, and
there were no interaction effects.
To examine genes whose expression was suggested to be sensitive to both diet and genotype, we selected
Lcn13 and Lpl (Fig. 3C). In the case of Lcn13 all three parameters tested were significantly different. For
lipoprotein lipase, genotype and diet were significantly different but no interaction was confirmed.
DISCUSSION
The liver-specific deletion of the Por gene results in a complex phenotype that affects P450 pathways and
sterol and fatty acid metabolism. In the present study, we provide evidence that dietary fatty acids alter
hepatic Tg accumulation and the gene expression profile in LCN mice as well as controls. The fish/fungal
diet, high in the HUFA AA, EPA, and DHA, reduced the total amount of Tg and cholesterol in liver and
had a substantial, primarily suppressive, effect on hepatic gene expression. Surprisingly, the impact of the
canola diet, high in the PUFA LN and LA, on gene expression and lipid accumulation was more similar to
the lard diet, which was low in PUFA and HUFA but high in SFA. The impact on LCN gene expression
was such that most fatty acid and sterol metabolic genes identified were primarily influenced by diet over
genotype. The relatively subdued effects of Por deletion on the expression of fatty acid and sterol
metabolic genes in mice fed with the three synthetic diets are in sharp contrast to the large genotype effects
seen previous by us and others in mice fed standard lab chow (43, 45). Analysis of gene expression changes
clearly distinguished effects related to diet and effects related to genotype with few overlapping or
Defining a relationship between dietary fatty acids and the cytochrome ... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055711/?report=printable
10 of 31 8/31/2016 9:32 AM
interactive differences. Thus, the synthetic diets in which only the fat component was different were useful
to scrutinize the impact of POR on hepatic metabolic genes and resulted in distinguishing those involved in
P450-related pathways, oxidative stress, and inflammation apart from lipid metabolism.
Most evidence to date specifically implicates DHA as the fatty acid that is responsible for modulation of
genes encoding enzymes of fatty acid metabolism by SREBP1, as well as for many PPAR-dependent
effects (20). In supplying diets enriched in the PUFA, LA and LN, we were able to distinguish the
precursor-product relationship between PUFA and HUFA. Liver is able to efficiently convert LN to DHA
as evidenced by the low levels of LN that accumulated in livers of animals fed the canola diet. However,
this did not result in the same regulatory impact as the fish/fungal diet containing preformed DHA. In fact,
when estimating significant differences between diets, we found the expression patterns in livers of mice
fed the canola diet were more similar to those fed the lard diet than to the fish/fungal diet. The lard and
canola diets also caused steatosis in both control and LCN livers, while lipid accumulation in livers of
animals fed the fish/fungal diet was more limited. These results are important given the very low HUFA
content of the traditional western diet and preponderance of LA as the essential PUFA in that diet. It also
points to the importance of differentiating between dietary intake of the various omega 3 fatty acids for
apparent health benefits.
Apart from individual gene analysis, further insights were provided by performing GSEA. As expected,
sterol and fatty acid metabolic pathways were identified by the comparison between diets. In addition, we
also noted the consistent occurrence of signaling pathways related to insulin-dependent regulation and
sensitivity to insulin. These pathways share genes including: AKT1/PKB, AKT2, AKT3, MAPK1,
MAPK3, MAPK8/JNK, INSR, INS1, INS2, INS4, SOS1, SOS2, PIK3CA, and RAF1 (reviewed in Refs.
35, 47). For example, AKT1 is included in 18 identified pathways, PIK3CA in 22, and MAPK8/JNK in 9.
The AKT signaling pathway has also been implicated in a number of processes required to maintain
cellular homeostasis by regulating protein synthesis and survival processes (17, 35, 47).
Also identified by GSEA with genes in common with the insulin signaling pathways were the PTEN,
growth hormone, and several MAPK and signaling pathways. Similar signaling events involving the
MAPKs occur in inflammation, immune function, and cell growth and adhesion (17, 35, 47). For this
reason, these insulin-related signaling molecules are also associated with cancer and are identified here in
several cancer pathways (e.g., HAS05211_RENAL_CELL_CARCINOMA and HSA05212_PANCREATIC
CANCER) (6, 17, 27). Overall, the coordinate identification of the lipid metabolic pathways, insulin,
growth hormone and some cancer/cell growth pathways reflects the strong association between nutrient
fatty acids and cellular homeostasis that is so critical to health maintenance (17).
Among the 53 pathway sets selected by GSEA using genotype as the criterion was one (HSA00980) that
included genes involved in the metabolism of xenobiotics by cytochrome P450. Another group of genes
was repeated in seven sets: GSTM1, GSTM2, and GSTM3. The GSTM gene products are glutathione
S-transferase M enzymes involved in phase II drug metabolism and have been implicated in oxidative
stress pathways. Also repeated in seven other identified pathways were CALM1, CALM2, and CALM3.
The Ca /calmodulin pathway has been implicated in induction of the P450 pathway genes and enzymes
by various drugs and xenobiotics such as phenobarbital (28). While these gene associations are not as
strong as those identified for the diet effects, they point to important regulatory and metabolic
interrelationships between these pathways and liver POR activity.
Very few studies have been conducted evaluating the impact of essential nutrients on the P450 system.
However, recently the Wolf lab reported a study in which they placed liver specific POR-deficient mice on
diets with either no fat or added saturated, monounsaturated, or polyunsaturated fat enriched in C18:2ω6
(10). Similar to this report, they found the PUFA were very potent effectors of Tg accumulation in these
livers. Only a diet completely deficient in fat prevented the steatosis generally associated with LCN mice.
2+
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These investigators examined the expression of certain CYP genes and found a connection between fat
accumulation and CYP induction that was dependent upon the transcription factor CAR. However, because
they did not evaluate any expression changes for fatty acid metabolic genes, nor did they conduct an
expression array analysis, it is unclear whether CAR contributes to steatosis by regulating these metabolic
genes as well. Given the patterns of gene expression we have uncovered as differentially expressed due to
dietary fat it seems more likely that at least SREBP1 and PPARα are playing a regulatory role in this
complex phenotype as well.
LCN animals accumulated more PUFA than controls (Supplemental Table S2), indicating conversion of
PUFA to HUFA was dampened. However, it was not completely suppressed and the LCN livers
accumulated more Tg than controls even when they were fed the fish/fungal diet rich in HUFA. This
suggests that the HUFA-dependent regulatory processes are not optimal in the absence of P450 reductase.
We speculate this is due to a reduced capacity to synthesize the proximal ligand(s) necessary for maximal
suppression of the fatty acid synthetic genes. A focus of future work will be to investigate whether or not
the effectors are CYP-dependent DHA metabolites. Taken together, our results demonstrate that the liver
P450 systems have a major impact on the subsequent metabolism of lipid nutrients and this may result in
downstream regulatory effects.
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Table 1.
Body weights, organ weights, and blood and plasma chemistry parameters
Genotype Lard Canola Fish/Fungal Significance, P
Body and Organ Weights
Body, g Ctrl 26.6 (1.1) 25.8 (4.4) 25.6 (0.6) Diet NS
LCN 24.98 (1.0) 25.1 (0.5) 24.7 (0.8) Geno NS
D*G NS
Liver, g Ctrl 1.17 (0.07) 1.18 (0.9) 1.15 (0.04) Diet NS
LCN 1.48 (0.09) 1.33 (0.07) 1.39 (0.03) Geno 0.0002
D*G NS
Liver: Body Ctrl 0.04 (0) 0.05 (0) 0.05 (0) Diet NS
LCN 0.06 (0) 0.05 (0) 0.06 (0) Geno <0.0001
D*G NS
Adipose Ctrl 0.59 (0.12) 0.74 (0.1) 0.45 (0.06) Diet NS
Tissue, g LCN 0.67 (0.08) 0.58 (0.07) 0.50 (0.06) Geno NS
D*G NS
Blood and Plasma Chemistry
ALP, U/l Ctrl 68.7 (6.4) 79.5 (5.2) 73.3 (0.9) Diet NS
LCN 93.8 (7.9) 92.3 (4.2) 109.3 (18.1) Geno 0.0040
D*G NS
ALT, U/l Ctrl 34.7 (9.3) 20.0 (3.2) 16.8 (2.5) Diet NS
LCN 154.3 (79.0) 97.0 (37.0) 34.0 (9.3) Geno 0.0192
D*G NS
TBIL, mg/dl Ctrl 0.35 (0.02) 0.35 (0.03) 0.35 (0.03) Diet NS
LCN 0.30 (0.00) 0.30 (0.00) 0.38 (0.03) Geno NS
D*G NS
ALB, g/dl Ctrl 3.9 (0.2) 4.0 (0.2) 4.2 (0.2) Diet NS
LCN 3.9 (0.2) 3.6 (0.1) 3.6 (0.1) Geno 0.0332
D*G NS
BUN, mg/dl Ctrl 17.0 (0.9) 19.5 (1.0) 19.5 (0.9) Diet NS
LCN 19.3 (2.8 15.3 (0.3) 19.0 (2.6) Geno NS
D*G NS
CHOL, mg/dl Ctrl 132.2 (8.3) 122.9 (10.9) 88.3 (5.2) Diet 0.0020
LCN 81.5 (5.4) 74.0 (7.1) 73.0 (5.8) Geno <0.0001
D*G 0.0245
TG, mg/dl Ctrl 33.8 (5.6) 35.3 (5.1) 19.9 (4.6) Diet 0.0237
LCN 16.0 (6.2) 8.3 (4.4) 4.7 (4.1) Geno 0.001
D*G NS
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Genotype Lard Canola Fish/Fungal Significance, P
GLUC, mg/dl Ctrl 187.7 (7.3) 181.7 (15.4) 136.0 (11.5) Diet 0.0007
LCN 171.0 (7.7) 174.4 (8.6) 139.4 (11.4) Geno NS
D*G NS
Values are the mean for 6–9 mice; values in parentheses indicate SE. Significance of difference was evaluated by 2-way
ANOVA (P < 0.05; t-test). ALP, alkaline phosphatase; ALT, alanine aminotransferase; TBIL, total bilirubin; ALB, albumin;
BUN, blood urea nitrogen; CHOL, total cholesterol; TG, triglyceride; GLUC, fasting (10 h) glucose; Geno, genotype; Ctrl,
control; D*G, diet × genotype; NS, not significant.
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Fig. 1.
Steatosis in livers of controls and LCN mice fed lard or canola diets. Representative liver micrographs at ×10
magnification from control or LCN mice fed each of the diets as indicated. Sections were stained with hematoxylin and
eosin.
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Fig. 2.
Hepatic triglyceride and cholesterol levels in control and LCN mice fed the 3 test diets. Triglycerides (A) and cholesterol
(B) were extracted from livers as detailed in the text. Gray bars indicate data for controls and black bars for LCN; n = 7
mice per group. The error bar gives SE. Data were analyzed using 2-way ANOVA and the Student's t-test; significance
values are as indicated.
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Table 2.
Hepatic fatty acid content (mol %) for controls and LCNs fed each of the experimental diets
Fatty Acid Genotype Lard mol% (SE) Canola mol% (SE) Fish/Fungal mol% (SE) FA Class Significance, P
C14:0 Ctrl 0.7 (0.0) 0.6 (0.1) 0.5 (0.0)
LCN 0.6 (0.0) 0.6 (0.0) 0.5 (0.1)
C16:0 Ctrl 21.5 (0.3) 21.9 (0.9) 26.4 (0.4)
LCN 19.0 (0.5) 18.5 (0.7) 21.1 (0.5)
C18:0 Ctrl 5.8 (1.2) 5.6 (0.6) 12.8 (0.8)
LCN 4.8 (0.2) 4.4 (0.3) 7.3 (0.4)
C20:0 Ctrl 0.3 (0.0) 0.2 (0.0) 0.3 (0.1)
LCN 0.5 (0.1) 0.4 (0.0) 0.4 (0.1)
C22:0 Ctrl 0.1 (0.0) 0.0 (0.0) 0.2 (0.1)
LCN 0.2 (0.0) 0.1 (0.0) 0.2 (0.1)
Σ SFA Ctrl 28.7 (1.5) 28.4 (1.0) 40.4 (1.1) Diet <0.0001
LCN 25.2 (0.6) 24.0 (0.8) 29.7 (0.8) Geno <0.0001
D*G 0.0006
C16:1 Ctrl 8.3 (1.0) 7.1 (0.7) 3.0 (0.5)
LCN 9.3 (0.3) 8.3 (0.6) 4.4 (0.5)
C18:1 Ctrl 44.2 (2.8) 39.7 (2.1) 14.2 (1.5)
LCN 47.4 (0.9) 46.4 (1.0) 25.1 (2.0)
C20:1 Ctrl 1.9 (0.3) 1.2 (0.2) 0.0 (0.0)
LCN 2.9 (0.2) 2.1 (0.1) 0.7 (0.1)
C22:1 Ctrl 0.2 (0.1) 1.5 (0.1) 0.4 (0.2)
LCN 0.5 (0.1) 0.2 (0.0) 0.2 (0.1)
Σ MUFA Ctrl 54.6 (4.1) 48.2 (3.0) 17.7 (2.0) Diet <0.0001
LCN 60.0 (1.0) 57.2 (1.4) 30.5 (2.5) Geno <0.0001
D*G NS
C18:2ω3 Ctrl 7.4 (1.0) 10.6 (1.0) 5.6 (0.6)
LCN 8.3 (0.3) 11.0 (0.7) 6.4 (0.5)
C18:3ω6 Ctrl 0.1 (0.0) 1.3 (0.3) 0.1 (0.0)
LCN 0.1 (0.1) 1.9 (0.2) 0.8 (0.1)
C20:3ω9 Ctrl 1.1 (0.3) 0.7 (0.2) 0.8 (0.2)
LCN 1.0 (0.1) 0.7 (0.1) 1.4 (0.1)
Σ PUFA Ctrl 7.5 (1.0) 11.9 (1.2) 5.7 (0.6) Diet <0.0001
LCN 8.4 (0.3) 12.7 (0.9) 7.2 (0.5) Geno NS
D*G NS
C20:4ω6 Ctrl 6.0 (1.4) 4.5 (0.8) 19.6 (0.8)
LCN 3.4 (0.1) 2.4 (0.2) 15.4 (0.5)
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Fatty Acid Genotype Lard mol% (SE) Canola mol% (SE) Fish/Fungal mol% (SE) FA Class Significance, P
C20:5ω3 Ctrl 0.0 (0.0) 0.8 (0.1) 0.9 (0.1)
LCN 0.0 (0.0) 0.5 (0.0) 1.4 (0.1)
C22:6ω3 Ctrl 2.0 (0.4) 5.5 (1.0) 15.0 (1.0)
LCN 1.7 (0.1) 2.2 (0.5) 14.2 (1.9)
Σ HUFA Ctrl 8.0 (1.8) 10.7 (1.9) 35.4 (1.2) Diet <0.0001
LCN 5.1 (0.2) 5.0 (0.7) 31.1 (2.1) Geno 0.0009
D*G NS
The percentage of the fatty acids in each class (SFA, MUFA, PUFA, HUFA) is noted. Data shown are means (± SE) of 6–7
animals per group. Significance of difference was evaluated by 2-way ANOVA; significance values are as indicated.
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Table 3.
Hepatic genes differentially expressed in response to dietary fat
Gene C/L L/FF C/FF Protein/Function
Fatty Acid Metabolism and Transport
Acacb ns 5.33 3.46 acetyl-Coenzyme A carboxylase beta
Acsl3 0.74 3.73 1.37 acyl-CoA synthetase long-chain family member 3
Acsl4 0.65 1.48 ns acyl-CoA synthetase long-chain family member 4
Acsm2 ns 0.61 0.43 acyl-CoA synthetase medium-chain family member 2
Acly 0.53 3.73 1.98 ATP citrate lyase
Acbp/ Dbi ns 1.30 1.22 Acyl-CoA binding protein
Echdc1 0.83 1.80 1.50 enoyl Coenzyme A hydratase domain containing 1
Elovl2 0.83 2.03 1.68 FA elongase family member 2
Elovl5 ns 5.81 4.70 FA elongase family member 5
Fabp2 ns 1.98 2.21 Fatty acid binding protein 2
Fabp5 0.39 5.62 2.17 Fatty acid binding protein 5
Fads1 ns 6.43 4.94 Fatty acid desaturase 1
Fads2 ns 5.05 3.92 Fatty acid desaturase 2
Fasn ns 6.56 3.68 Fatty acid synthase
Tecr/Gpsn2 ns 1.49 1.28 Trans-2,3-enoyl-CoA reductase
Pcyt2 ns 1.67 1.57 CTP:phosphoethanolamine cytidylyltransferase 2
Gpcpd1/Prei4 ns 0.49 0.61 Glycerophosphocholine phosphodiesterase GDE1 homolog
Sterol Metabolism
Cyp51 0.66 4.17 2.03 Cytochrome P450 51
Dhcr7 ns 2.27 1.84 7-dehydrocholesterol reductase
Fdps ns 6.17 4.10 Farnesyl diphosphate synthetase;
Hmgcs1 ns 2.19 1.79 HMG CoA synthase
Idi1 ns 7.07 4.59 Isopentenyl-diphosphate delta isomerase
Insig1 ns 2.34 1.87 Insulin-induced gene 1
Lss ns 2.03 1.61 Lanosterol synthase
Nsdhl ns 2.50 1.76 NAD(P) dependent steroid dehydrogenase-like
Pmvk ns 2.15 1.60 Phosphomevalonate kinase
Rdh11 ns 3.64 2.56 Retinol dehydrogenase 11
Retsat 1.58 0.62 ns Retinol saturase
Sc4mol 0.75 2.18 1.58 Sterol-C4-methyl oxidase-like
Sc5d 0.77 1.87 1.44 Sterol-C5-desaturase
Sqle 0.49 3.40 ns Squalene epoxidase
Stard4 ns 2.77 2.27 Steroidogenic acute regulatory-related lipid transfer (START) domain containing 4
Carbohydrate metabolism
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Gene C/L L/FF C/FF Protein/Function
Dlat ns 1.34 1.28 dihydrolipoamide S-acetyltransferase
Gpsn2 ns 1.49 1.28 Glycoprotein
Pgm3 ns 1.62 1.48 phosphoglucomutase 3
Membrane transport
Aqp4 ns 2.26 4.15 aquaporin 4
Mfsd2 ns 9.75 10.9 major facilitator superfamily domain containing 2
Slc10a2 0.74 1.63 ns solute carrier family 10
Slc30a10 ns 1.77 1.59 solute carrier family 30
Apolipoproteins
Apoa4 ns 8.58 8.10 Apolipoprotein A-IV
Apoa5 ns 1.21 1.22 Apolipoprotein A-V
Apoc2 ns 1.49 1.62 Apolipoprotein C-II
Cell Adhesion/Cytoskeletal
Olfm3 ns 1.69 1.59 olfactomedin 3
Pstpip2 0.71 2.34 1.90 Pro-ser-thr-phosphatase-interacting protein 2
Tjp3 ns 1.52 1.51 Tight junction protein 3
Arhgap24/Filgap ns 1.59 1.41 Rho GTPase activating protein 24
Regulation
Atf5 ns 2.08 1.92 Activating transcription factor 5
Bace2 0.83 0.88 0.72 Beta-site APP-cleaving enzyme 2
Camk1d ns 2.96 2.25 calcium/calmodulin-dependent protein kinase ID
Rassf6 ns 1.54 ns Ras association (RalGDS/AF-6) domain family 6
Rgs3 ns 3.01 2.34 regulator of G protein signaling 3
Sema4a 0.88 1.25 1.11 sema domain/Semaphorin-4A
Vegfb ns 1.57 1.42 vascular endothelial growth factor B
Others
Car14 ns 0.68 0.63 carbonic anhydrase 14
Cxadr 0.70 2.05 1.45 coxsackievirus and adenovirus receptor
Ddx58 ns 1.43 1.22 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
Dntt ns 1.67 1.37 deoxynucleotidyltransferase
Enpep ns 1.41 1.31 glutamyl aminopeptidase
Fkbp14 0.80 1.46 1.17 FK506 binding protein 14
Frmd4b 0.78 2.12 1.62 FERM domain containing 4B
H2-K1 0.89 1.30 1.17 histocompatibility 2
H2-Q10 ns 1.43 1.38 histocompatibility 2
H2-Q6 0.79 1.52 1.19 histocompatibility 2
Limd2 ns 0.69 0.72 LIM domain containing 2
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Gene C/L L/FF C/FF Protein/Function
Lonp2 1.20 0.75 ns lon peptidase 2
Mfsd2 ns 9.75 10.89 major facilitator superfamily domain containing 2
Oprs1 ns 1.33 1.24 opioid receptor
Paqr9 ns 2.20 2.33 progestin and adipoQ receptor family member IX
Pnpla7 ns 1.56 1.50 patatin-like phospholipase domain containing 7
Pter ns 1.67 1.48 phosphotriesterase related
Tm7 sf2 ns 1.80 1.71 transmembrane 7 superfamily member 2
Ube2i ns 1.24 1.17 ubiquitin-conjugating enzyme E2I
Unknowns
ns 1.59 1.35 RIKEN cDNA 1110059G02 gene
0.75 1.63 1.22 RIKEN cDNA 1600029D21 gene
ns 2.67 1.88 RIKEN cDNA 1810008I18 gene
1.20 0.82 ns RIKEN cDNA 2410001C21 gene
ns 0.74 0.68 RIKEN cDNA 6430514L14 gene
ns 4.84 2.61 RIKEN cDNA 9130221J18 gene
ns 1.82 2.00 RIKEN cDNA C730029A08 gene
ns 1.97 1.47 RIKEN cDNA D130043K22 gene
ns 1.43 1.32 RIKEN cDNA D730039F16 gene
Data are expressed as ratios when identified as significant at q < 0.05 using 1-way ANOVA with Benjamini-Hochberg false
discovery rate (FDR) correction; ns, not significant; L, lard; C, canola; FF, fish fungal. Protein/function identification is from
the UniProtKB/Swiss-Prot Database.
Defining a relationship between dietary fatty acids and the cytochrome ... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055711/?report=printable
25 of 31 8/31/2016 9:32 AM
Table 4.
Genes whose expression is different due to genotype
Gene KO/C Protein Name/Function
Regulation
Rarb 1.66 retinoic acid receptor beta
Metabolism
Acp2 1.51 acid phosphatase 2
Anxa2 1.60 annexin A2; calpactin 1
Anxa5 1.60 annexin A5
Ces6 2.11 carboxylesterase 6
Idh2 1.56 isocitrate dehydrogenase
Lpl 2.53 lipoprotein lipase
Rarres1 1.63 retinoic acid receptor responder 1
Sdro 0.53 orphan short chain dehydrogenase
Smpd3 1.85 sphingomyelin phosphodiesterase 3
Membrane Transport
Abcb1a 2.38 ATP-binding cassette
Abcc3 2.28 ATP-binding cassette
Slc16a7 1.62 solute carrier family 16 transporter
Slc3a1 0.63 solute carrier family 3 a1 transporter
Slco1a4 3.10 solute carrier family 1a4 transporter
Oxidative Stress
Gpx7 1.76 glutathione peroxidase 7
Gsta1 2.91 glutathione S-transferase a1
Gsta4 1.56 glutathione S-transferase m4
Gstm1 1.53 glutathione S-transferase m1
Gstm3 8.46 glutathione S-transferase m3
Inflammatory Response
Akr1b3 1.51 aldo-keto reductase family1b3
Akr1b7 1.97 aldo-keto redcutase family 1b7
Il1rn 2.01 interleukin 1 receptor antagonist
Hspb1 1.51 heat shock protein 1
Lcn2 3.93 lipocalin 2
Mmp12 3.00 matrix metallopeptidase 12
Orm3 2.16 orosomucoid 3
Serpinb1a 2.96 serpin peptidase inhibitor b1a
Serpinb6b 2.08 serpin peptidase inhibitor 6b
Serpina4 0.36 serpin peptidase inhibitor a4
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Gene KO/C Protein Name/Function
Tgfbr2 1.56 transforming growth factor
Tnfrs19 2.23 tumor necrosis factor receptor 19
Cytochrome P450 Enzymes
Cyp1a2 1.56 cytochrome P450 1a2
Cyp26a1 2.69 cytochrome P450 26a1
Cyp2b1 127.69 cytochrome P450 2b10
Cyp2c54 1.67 cytochrome P450 2c54
Cyp2c55 17.87 cytochrome P450 2c55
Cyp2u1 0.65 cytochrome P450 2u1
Cyp3a41a 1.86 cytochrome P450 3a41a
Ubiquitination
Usp18 1.57 ubiquitin-specific peptidase 18
Ubd 2.38 ubiquitin D
Yod1 0.65 YOD1 deubiquitinating enzyme 1
Others
Basp1 1.52 brain abundant
Casc4 1.51 cancer susceptibility candidate 4
Cml4/Nat8 0.56 camello-like 4; N-acetyl tranferase
Cotl1 1.64 coactosin-like 1 (Dictyostelium)
D1Ertd471e 1.82 DNA segment
Eid1 1.50 EP300 interacting inhibitor of differentiation 1
Entpd5 1.65 ectonucleoside triphosphate diphosphohydrolase 5
Flvcr2 1.55 feline leukemia virus subgroup C cellular receptor family
Gdf15 1.91 growth differentiation factor 15
H2-Aa 1.54 histocompatibility 2
Lgals7 1.67 lectin
Ndrg1 1.82 N-myc downstream regulatory gene 1
Nebl 4.79 nebulette; thin filament protein
Ptpla 1.50 protein tyrosine phosphatase-like
Pvr 1.59 poliovirus receptor
Pvt1 1.70 plasmacytoma variant translocation 1
Rhbg 1.66 Rhesus blood group-associated B glycoprotein
Rragd 1.91 Ras-related GTP binding D
Snx17 0.60 sorting nexin 17
Sulf2 1.54 sulfatase 2
Tlr2 1.52 Toll-like receptor 2
Tmed3 1.51 transmembrane emp24 domain containing 3
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Gene KO/C Protein Name/Function
Tmem120a 0.47 transmembrane protein 120A
Tmem176a 1.53 transmembrane protein 176A
Tmem51 1.53 transmembrane protein 51
Ugt2b37 2.73 UDP glucuronosyltransferase 2 family
Unknowns
1810023F06Rik 1.61 RIKEN cDNA 1810023F06
4931406C07Rik 1.71 RIKEN cDNA 4931406C07
? 2.29 0 day neonate lung cDNA
Data are expressed as ratio of LCN vs. control (KO/C) when identified as significant at q < 0.05 using the t-test with
Benjamini-Hochberg FDR correction. Protein/function identification is from the UniProtKB/Swiss-Prot Database.
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Table 5.
Hepatic genes whose expression is significantly different due to both diet and genotype
Gene Ctl L KO L Ctl C KO C Ctl FF KO FF P Value Protein Name/Function
Fatty Acid Metabolism
Elovl1 0.02 0.30 −0.20 0.08 −0.64 −0.01 0.011 FA elongation
Lcn13 −0.15 −0.81 −0.14 −0.58 2.81 0.13 0.003 lipocalin 13
Lpl −0.20 0.89 −0.59 0.43 −0.35 1.55 0.003 lipoprotein lipase
Ppt1 −0.02 0.01 −0.07 −0.07 0.18 0.04 0.014 palmitoyl-protein thioesterase 1
Inflammation/Inflammatory Response
Mmp12 −0.44 2.43 −0.15 0.83 −0.23 0.68 0.012 matrix metallopeptidase 12
Regulation
Vegfb 0.20 0.18 0.17 −0.07 −0.62 −0.30 0.007 vascular endothelial growth factor B
Creb3l2 −0.25 0.21 −0.16 0.02 0.01 0.01 0.002 cAMP responsive element binding protein 3-like 2
Others
Adamts16 0.17 −0.02 0.01 0.00 0.00 −0.09 0.011 A disintegrin-like and metallopeptidase
Clcn6 0.01 0.20 −0.03 −0.01 −0.33 0.04 0.006 chloride channel 6
Col23a1 0.00 −0.27 0.07 0.03 0.00 −0.02 0.001 procollagen
Dsn1 −0.11 0.27 −0.14 0.06 0.03 0.00 0.002 MIND1 kinetochore complex component
Gpc1 0.44 −0.07 0.56 −0.14 −0.25 −0.10 0.000 glypican 1
Gpr137b −0.38 0.94 −0.25 0.12 0.04 0.20 0.008 G protein-coupled receptor 137B
Neu1 −0.08 0.05 0.00 0.07 −0.24 0.13 0.009 neuraminidase 1
Odf1 0.01 0.04 0.12 −0.21 0.02 −0.15 0.002 outer dense fiber of sperm tails 1
Rbpms −0.35 0.03 −0.32 0.02 0.08 0.13 0.014 RNA binding protein gene with multiple splicing
Sgcg 0.14 −0.19 0.18 −0.16 0.01 −0.04 0.002 sarcoglycan
Tmem120a 0.23 −0.39 0.49 −0.33 0.52 −1.27 0.003 transmembrane protein 120A
Tmem97 0.05 0.24 0.01 0.13 −0.65 −0.02 0.015 transmembrane protein 97
Wdr51b 0.24 0.11 −0.16 −0.06 −0.07 0.02 0.004 WD repeat domain 51B
Wrnip1 −0.24 0.11 −0.11 0.05 −0.10 0.35 0.014 Werner helicase interacting protein 1
Unknown
−0.01 −0.01 0.06 −0.12 0.21 −0.03 0.003 RIKEN cDNA 9030224M
Log2 transformed fold change and significance were calculated by 2-way ANOVA, q < 0.01. Ctl, control; KO, LCN; L, lard;
C, canola; FF, fish/fungal.
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Fig. 3.
Quantitation of expression of specific genes using Q-PCR. Genes were selected among those that showed significant
differences in expression on arrays due to diet (A), genotype (B), or both diet and genotype (C). Gene designations are as
indicated in the text. Gray bars indicate data for controls and black bars for LCN. Data are expressed relative to the value
for control lard within each experiment; n = 6–8 mice per group. The error bar gives SE. Data analyzed using 2-way
ANOVA and the Student's t-test; significance values are as indicated.
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Fig. 4.
Protein expression in control and LCN livers from mice fed the 3 test diets. Representative images are for fatty acid
synthase (Fasn) and Δ9-stearyl-CoA desaturase (Scd1) as indicated. β-Actin served as a loading control.
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